VERTEX PHARMACEUTICALS INCORPORATED Funds and ETFs Vertex Pharmaceuticals Incorporated
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 454.7 USD | +0.87% |
|
+1.96% | +11.56% |
| May. 22 | Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing | MT |
| May. 21 | ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment | MT |
ETFs positioned on Vertex Pharmaceuticals Incorporated
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.67% | 0 M€ | 0.00% | - | |
| 7.08% | 0 M€ | 0.00% | - | |
| 5.20% | 2 M€ | -.--% | ||
| 4.81% | 7 M€ | -.--% | - | |
| 4.05% | 110 M€ | +9.97% | - | |
| 3.53% | 1 M€ | 0.00% | - | |
| 2.32% | 2 M€ | 0.00% | ||
| 2.28% | 8 M€ | 0.00% | ||
| 1.99% | 12 M€ | +15.09% | - | |
| 1.93% | 0 M€ | 0.00% | - | |
| 1.71% | 2 M€ | -25.75% | ||
| 1.63% | 17 M€ | +7.15% | - | |
| 1.61% | 253 M€ | +6.91% | ||
| 1.58% | 9 M€ | -4.31% | - | |
| 1.10% | 204 M€ | +10.54% | ||
| 1.06% | 1,100 M€ | +4.31% | ||
| 0.87% | 9 M€ | -.--% | - | |
| 0.82% | 13 M€ | -.--% | - | |
| 0.82% | 3 M€ | +15.16% | - | |
| 0.82% | 4 M€ | -.--% | - | |
| 0.81% | 26 M€ | +16.85% | - | |
| 0.73% | 15 M€ | 0.00% | - | |
| 0.69% | 5 M€ | -72.95% | - | |
| 0.68% | 3 M€ | 0.00% | - | |
| 0.51% | 727 M€ | +8.70% |
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Calendar
2024-06-04
- William Blair Growth Stock Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
450.8
USD
Average target price
462.8
USD
Spread / Average Target
+2.66%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.56% | 116B | |
| +12.37% | 106B | |
| -7.09% | 23.89B | |
| -3.11% | 21.58B | |
| -10.90% | 18.96B | |
| -40.50% | 16.96B | |
| -13.67% | 16.33B | |
| +7.08% | 14.14B | |
| +33.56% | 12.02B | |
| -2.11% | 7.58B |
- Stock Market
- Equities
- VRTX Stock
- Funds and ETFs Vertex Pharmaceuticals Incorporated
